REFLAB ApS: Financial statements 2017
CVR: 15322586
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
REFLAB ApS (CVR 15322586) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,782,613 and a net result of DKK -1,008,355 compared with DKK -1,802,778 the year before. That is an increase of 60.6% compared with the year before. Equity in the 2017 report amounted to DKK 668,756. The solvency ratio was 15.6%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 2,782,613
- Profit/Loss
- DKK -1,008,355
- Equity
- DKK 668,756
- Total Assets
- DKK 4,292,625
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 2.8 mio. | -1 mio. | 669 t. | 7 |
| 2016 | - | 1.7 mio. | -1.8 mio. | 1.7 mio. | 6 |
| 2015 | - | 3 mio. | -382 t. | 3.5 mio. | - |
| 2014 | - | 4.6 mio. | 1.1 mio. | 3.9 mio. | - |
| 2013 | - | 3.7 mio. | 98 t. | 2.8 mio. | - |
Official annual report
Keep an eye on REFLAB ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 20, 2017, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of REFLAB ApS.
As of December 20, 2017, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of REFLAB ApS.
REFLAB ApS has published its annual report for 2016. Gross profit came to DKK 1,732,908, and the net result was DKK -1,802,778.
About REFLAB ApS
REFLAB ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 1991. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named REFERENCELABORATORIET ApS. The management consists of Gert Pynt Andersen and Katrine Baumann Markussen. The company is owned by R-Biopharm AG. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 4,582,184 and a net result of DKK -1,792,430 compared with DKK 652,577 the year before. Equity in the 2025 report amounted to DKK -635,048.